376 related articles for article (PubMed ID: 5774574)
1. Fluphenazine enanthate for the difficult psychotic patient.
Stewart AR; Lavallee B
Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
[No Abstract] [Full Text] [Related]
2. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
Haumonté MT; Hoerdt HP
Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
[No Abstract] [Full Text] [Related]
3. [Clinical experience with fluphenazine decanoate in psychoses].
Náhunek K; Rodová A; Svestka J
Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564
[No Abstract] [Full Text] [Related]
4. Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
van Praag HM; Dols LC
Am J Psychiatry; 1973 Jul; 130(7):801-4. PubMed ID: 4576449
[No Abstract] [Full Text] [Related]
5. [Clinical experience with fluphenazine Depot].
Vencovský E; Sedivec V; Peterová E; Baudis P; Dvoráková M
Act Nerv Super (Praha); 1970 Jan; 12(1):49-50. PubMed ID: 5418656
[No Abstract] [Full Text] [Related]
6. Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
Karkalas Y
Curr Ther Res Clin Exp; 1968 Apr; 10(4):196-200. PubMed ID: 4967873
[No Abstract] [Full Text] [Related]
7. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
[No Abstract] [Full Text] [Related]
8. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
9. [Clinical therapeutic experiences with fluphenazine].
Pfeiffer WM
Arzneimittelforschung; 1967 Oct; 17(10):1327-9. PubMed ID: 5632888
[No Abstract] [Full Text] [Related]
10. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
[No Abstract] [Full Text] [Related]
11. [Fluphenazine enanthate, delayed-action neuroleptic dru utilizable in outpatients treatment of chronic psychosis].
Lambert PA; Midenet M; Marcou G; Bouchardy M
J Med Lyon; 1967 Mar; 48(116):351-5. PubMed ID: 5614941
[No Abstract] [Full Text] [Related]
12. [Direct treatment of psychotic symptoms with an incisive neuroleptic (Dapotum Acutum)].
Bermejo E
Rev Med Suisse Romande; 1976 Dec; 96(12):951-3. PubMed ID: 1006000
[No Abstract] [Full Text] [Related]
13. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
Richou H
Ann Med Psychol (Paris); 1975 Jul; 2(2):399-402. PubMed ID: 9894
[No Abstract] [Full Text] [Related]
14. A clinical evaluation of prolixin enanthate.
Goldberg HL; DiMascio A; Chaudhary B
Psychosomatics; 1970; 11(3):173-7. PubMed ID: 5427131
[No Abstract] [Full Text] [Related]
15. [Experience in the management of chronic psychoses using fluphenazine-oenanthate].
Eichstetter F
Nervenarzt; 1968 Jun; 39(6):282-3. PubMed ID: 5712435
[No Abstract] [Full Text] [Related]
16. Depot fluphenazine: risk/benefit ratio.
Glazer WM
J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of depot fluphenazine in out-patient schizophrenics.
Crawford R; Forrest A
Br J Psychiatry; 1974 Apr; 124(0):385-91. PubMed ID: 4599422
[No Abstract] [Full Text] [Related]
18. Effects of single, combined, and non-drug treatments on chronic mental patients. (A preliminary study).
Williams JR; Solecki RT; Puttkammer S
Dis Nerv Syst; 1969 Oct; 30(10):696-701. PubMed ID: 5355303
[No Abstract] [Full Text] [Related]
19. [Management of psychotic drive disorders].
Langner E
Wien Med Wochenschr; 1968 Sep; 118(36):700-2. PubMed ID: 5679053
[No Abstract] [Full Text] [Related]
20. Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study.
Deverteuil R; Lehmann HE; Ban TA; Saxena BM
Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):219-22. PubMed ID: 5550418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
